TOKYO, Mar 27 (Pulse News Wire) – Olympus Corporation (7733.T) announced today changes to its board of directors following a meeting of the nomination committee. Two new external directors, Jean-Luc Buttet and Costas Saroukos, have been nominated for approval at the upcoming June shareholders' meeting.
Jean-Luc Buttet, born on November 08, 1956, brings extensive international experience from roles such as President at Medtronic Inc. and Baxter International Inc. He currently serves as a non-executive director at several companies, including Takeda Pharmaceutical and Novo Holdings.
Buttet holds no shares in Olympus. Costas Saroukos, born on April 15, 1971, joins the board with significant global finance expertise from positions including Chief Financial Officer at Takeda Pharmaceutical and Chairman of the Board at Mitsubishi Pharma. Saroukos also holds no shares in Olympus.
Both nominees are expected to enhance the board's governance and strategic advice, contributing to Olympus' long-term growth and shareholder value.
🟢 Confidence: High AI-translated content.